protein kinase C modulators (Terrapin)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameprotein kinase C modulators (Terrapin)
Drug Alias NameTER-14687TER-10311TER-17210
ClassificationSmall molecules
Mechanisms of ActionProtein kinase C modulatorsImmunomodulators
TargetsProtein kinase C
Therapy Area/IndicationsRejection of organ transplantationMultiple SclerosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMabvax Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabvax Therapeutics Holdings Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationMultiple SclerosisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A